Amgen, an American multinational biopharmaceutical company, has announced a $650 million expansion of its US manufacturing network, creating hundreds of new jobs.
The planned investment will support increased drug production at the company’s biologics manufacturing facility in Juncos and integrate innovative advanced technologies throughout the operations process. It is expected to create nearly 750 jobs, including construction roles and new highly skilled manufacturing jobs.
Robert A. Bradway, chairman and CEO at Amgen, says: “This expansion underscores Amgen’s commitment to US biomanufacturing and to strengthening the resilience of our global supply chain. [Read more…] about Amgen to invest $650 million to expand US manufacturing